Business Description
Zoetis Inc
NAICS : 325412
SIC : 2834
ISIN : US98978V1035
Share Class Description:
ZTS: Class ATotal Employee Number:
14,500Compare
Compare
Traded in other countries / regions
ZTS.USA0M3Q.UKZ1TS34.BrazilZOE.GermanyZTS.Mexico1ZTS.ItalyZTS.PeruZOTS.AustriaZTS.SwitzerlandZOE.Bulgaria Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
2013-02-01Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.94 | |||||
Debt-to-EBITDA | 2.31 | |||||
Interest Coverage | 15.05 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.64 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 9.5 | |||||
3-Year FCF Growth Rate | 22.2 | |||||
3-Year Book Growth Rate | -6.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 2.67 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.35 | |||||
9-Day RSI | 46.09 | |||||
14-Day RSI | 45.95 | |||||
3-1 Month Momentum % | -2.99 | |||||
6-1 Month Momentum % | -39.85 | |||||
12-1 Month Momentum % | -50.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.08 | |||||
Quick Ratio | 1.84 | |||||
Cash Ratio | 0.81 | |||||
Days Inventory | 335.71 | |||||
Days Sales Outstanding | 59.43 | |||||
Days Payable | 63.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.72 | |||||
Dividend Payout Ratio | 0.31 | |||||
3-Year Dividend Growth Rate | 15.4 | |||||
Forward Dividend Yield % | 2.76 | |||||
5-Year Yield-on-Cost % | 6.77 | |||||
3-Year Average Share Buyback Ratio | 2.9 | |||||
Shareholder Yield % | 8.2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.54 | |||||
Operating Margin % | 37.65 | |||||
Net Margin % | 27.49 | |||||
EBITDA Margin % | 41.95 | |||||
FCF Margin % | 24.34 | |||||
OCF Margin % | 29.84 | |||||
ROE % | 65.12 | |||||
ROA % | 17.36 | |||||
ROIC % | 24.76 | |||||
3-Year ROIIC % | 35.4 | |||||
ROC (Joel Greenblatt) % | 54.46 | |||||
ROCE % | 27.5 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.63 | |||||
Forward PE Ratio | 12.22 | |||||
PE Ratio without NRI | 11.65 | |||||
Shiller PE Ratio | 16.38 | |||||
Price-to-Owner-Earnings | 15.13 | |||||
PEG Ratio | 1.17 | |||||
PS Ratio | 3.4 | |||||
PB Ratio | 10.09 | |||||
Price-to-Free-Cash-Flow | 14.35 | |||||
Price-to-Operating-Cash-Flow | 11.67 | |||||
EV-to-EBIT | 11.18 | |||||
EV-to-Forward-EBIT | 11.94 | |||||
EV-to-EBITDA | 9.83 | |||||
EV-to-Forward-EBITDA | 10.27 | |||||
EV-to-Revenue | 4.12 | |||||
EV-to-Forward-Revenue | 4.22 | |||||
EV-to-FCF | 16.95 | |||||
Price-to-GF-Value | 0.42 | |||||
Price-to-Projected-FCF | 1.27 | |||||
Price-to-DCF (Earnings Based) | 0.56 | |||||
Price-to-DCF (FCF Based) | 0.58 | |||||
Price-to-Median-PS-Value | 0.39 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.38 | |||||
Earnings Yield (Greenblatt) % | 8.94 | |||||
FCF Yield % | 7.31 | |||||
Forward Rate of Return (Yacktman) % | 13.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ZTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Zoetis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9,517 | ||
| EPS (TTM) ($) | 6.07 | ||
| Beta | 0.5948 | ||
| 3-Year Sharpe Ratio | -0.97 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | 37.61 | ||
| 14-Day RSI | 45.95 | ||
| 14-Day ATR ($) | 2.868781 | ||
| 20-Day SMA ($) | 75.3765 | ||
| 12-1 Month Momentum % | -50.82 | ||
| 52-Week Range ($) | 71 - 160.48 | ||
| Shares Outstanding (Mil) | 413.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zoetis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zoetis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-12 08:30 | In 178 days | ||
| Annual report for 2026 | 2027-02-12 | In 177 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 177 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-04 08:30 | In 78 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 77 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 08:30 | 74.39 (-2.25%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 74.39 (-2.25%) | ||
| USD 0.530000 Cash Dividend | 2026-07-20 | 76.56 (-1.09%) | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-02 13:20 | 77.56 (+0.65%) | ||
| Guidance call for 2026 | 2026-05-28 15:00 | 79.48 (-0.67%) |
Show
Entries
Zoetis Inc Frequently Asked Questions
What is Zoetis Inc(ZTS)'s stock price today?
The current price of ZTS is $76.68. The 52 week high of ZTS is $160.48 and 52 week low is $71.00.
When is next earnings date of Zoetis Inc(ZTS)?
The next earnings date of Zoetis Inc(ZTS) is 2026-11-04 Est..
Does Zoetis Inc(ZTS) pay dividends? If so, how much?
The Dividend Yield % of Zoetis Inc(ZTS) is 2.72% (As of Today), Highest Dividend Payout Ratio of Zoetis Inc(ZTS) was 0.31. The lowest was 0.16. And the median was 0.21. The Forward Dividend Yield % of Zoetis Inc(ZTS) is 2.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Zoetis Inc
Headlines
See More- 1
Aug 06, 2026
Zoetis forecasts 2026 revenue of $9.12B-$9.32B as gross-to-net actions expand amid U.S. companion animal pressure
Seeking Alpha • 12:15pm
Zoetis taps James Saccaro as finance, operations chief
Seeking Alpha • 6:15am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers